Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (CTRI/2026/10/119285) titled 'Vitamin B12 supplementation in people with type 2 Diabetes and its role in managing nerve problems' on Oct. 9.
Study Type: Interventional
Study Design:
Other Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Not Applicable
Primary Sponsor: Sunidhi Singh
Condition:
Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications
Intervention:
Intervention1: Vitamin B12 supplementation: Dosage 1500 mcg injectible, daily for 7 days, followed by alternate day for one week, then once a week for 4 weeks and mon...